1-3 of 3
Sigurdur Y. Kristinsson
Close
Sort by
Journal Articles

Bone disease in monoclonal gammopathy of undetermined significance: results from a screened population-based study

Clinical Trials & Observations
Sigrun Thorsteinsdottir, Sigrun H. Lund, Ebba K. Lindqvist, Marianna Thordardottir, Gunnar Sigurdsson, Rene Costello, Debra Burton, Hlif Steingrimsdottir, Vilmundur Gudnason, Gudny Eiriksdottir, Kristin Siggeirsdottir, Tamara B. Harris, Ola Landgren, Sigurdur Y. Kristinsson
Journal: Blood Advances
Blood Adv (2017) 1 (27): 2790–2798.
https://doi.org/10.1182/bloodadvances.2017010454
Published: 2017
Journal Articles

The impact of prior malignancies on second malignancies and survival in MM patients: a population-based study

Clinical Trials & Observations
Gudbjörg Jonsdottir, Sigrún H. Lund, Magnus Björkholm, Ingemar Turesson, Malin Hultcrantz, Anna Porwit, Yogesh S. Jethava, Ola Landgren, Sigurdur Y. Kristinsson
Journal: Blood Advances
Blood Adv (2017) 1 (25): 2392–2398.
https://doi.org/10.1182/bloodadvances.2017007930
Published: 2017
Journal Articles

Obesity and risk of monoclonal gammopathy of undetermined significance and progression to multiple myeloma: a population-based study

Clinical Trials & Observations
Marianna Thordardottir, Ebba K. Lindqvist, Sigrun H. Lund, Rene Costello, Debra Burton, Neha Korde, Sham Mailankody, Gudny Eiriksdottir, Lenore J. Launer, Vilmundur Gudnason, Tamara B. Harris, Ola Landgren, Sigurdur Y. Kristinsson
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2186–2192.
https://doi.org/10.1182/bloodadvances.2017007609
Published: 2017